Amgen | Algorithmic Culture Magazine

Home>Amgen

With A Possibility For CRISPR To Cure “All” Diseases, Should All New Biotech Companies Be Designated Public Benefit Corporations (PBCs) To Thwart Potentially Specious Big Pharma Takeovers?

March 23, 2020

With A Possibility For CRISPR To Cure “All” Diseases, Should All New Biotech Companies Be Designated Public Benefit Corporations (PBCs) To Thwart Potentially Specious Big Pharma Takeovers?

A neoteric philosophy on CRISPR (Cas9 and other variants): biotech startups; takeovers; Big Pharma (potentially comprised with executives susceptible to unscrupulous …